Skip to main content

Advertisement

Log in

Primary testicular lymphoma: experience with 13 cases and literature review

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

To summarize the clinicopathological features, therapeutic regimens, and outcomes for patients with primary testicular lymphoma (PTL), we retrospectively reviewed the medical records of 13 patients diagnosed with PTL between 2001 and 2012 at our hospital. Average age at diagnosis was 62.2 ± 13.9 years, and all patients presented with painless testicular swelling. Diffuse large B-cell lymphoma was the dominant histotype (69.2 %). All 13 patients were treated with inguinal orchiectomy and received chemotherapy and/or radiotherapy. Complete follow-up data were available for 10 patients with an average follow-up duration of 28.4 ± 30.9 months. Seven patients were evaluated as Ann Arbor stage I or II, and three as stage III or IV. Eight patients were found to have hypoechogenic and hypervascular signals in the testis on ultrasound examination. Complete remission was achieved in six patients, and four patients who were still undergoing chemotherapy during the last follow-up showed no signs of relapse. Of the 10 patients with complete follow-up records, three had relapses, which occurred in the CNS, epiglottis, and the nasal cavity. Time to relapse in these cases was 2, 7, and 11 months, respectively (3/10). The mean progression-free survival was 22.57 months (range 1.1–101.9 months).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AFP:

Alpha-fetoprotein

β-HCG:

β-Human chorionic gonadotropin

CNS:

Central nervous system

CT:

Computed tomography

CR:

Complete remission

DLBCL:

Diffuse large B-cell lymphoma

DICE:

Dexamethasone, ifosfamide, cisplatin, and etoposide

ESHAP:

Etoposide, solumedrol (methylprednisolone), ara-C (high-dose cytarabine), and cisplatin

IPI:

International Prognostic Index

MRI:

Magnetic resonance imaging

NHL:

Non-Hodgkin’s lymphoma

OS:

Overall survival

PFS:

Progression-free survival

PTL:

Primary testicular lymphoma

References

  1. Fonseca R, Habermann TM, Colgan JP, O’Neill BP, White WL, Witzig TE, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000;88:154–61.

    Article  PubMed  CAS  Google Scholar 

  2. Balogun TM, Omodele FO, Olaiya MA. Primary lymphoma of the testis in remission for more than ten years: a case report. West Afr J Med. 2009;28:388–90.

    PubMed  CAS  Google Scholar 

  3. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med. 1986;81:515–24.

    Article  PubMed  CAS  Google Scholar 

  4. Hurley LJ, Burke CR, Shetty SK, Previte SR, Sakr OE, Libertino JA. Bilateral primary non-Hodgkin’s lymphoma of the testis. Urology. 1996;47:596–8.

    Article  PubMed  CAS  Google Scholar 

  5. Lagrange JL, Ramaioli A, Theodore CH, Terrier-Lacombe MJ, Beckendorf V, Biron P, et al. Non-Hodgkin’s lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol. 2001;12:1313–9.

    Article  PubMed  CAS  Google Scholar 

  6. Park BB, Kim JG, Sohn SK, Kang HJ, Lee SS, Eom HS, et al. Consideration of aggressive therapeutic strategies for primary testicular lymphoma. Am J Hematol. 2007;82:840–5.

    Article  PubMed  Google Scholar 

  7. Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc. 2007;99:1277–82.

    PubMed  Google Scholar 

  8. Conrad AL, Go RS. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma. Eur J Haematol. 2009;83:603–5.

    Article  PubMed  Google Scholar 

  9. Geetha N, Jayasree K, Ittiyavirah AK, Lali VS, Nair MK. Renal relapse in bilateral synchronous testicular lymphoma. Am J Clin Oncol. 2000;23:290–1.

    Article  PubMed  CAS  Google Scholar 

  10. Sasai K, Yamabe H, Tsutsui K, Dodo Y, Ishigaki T, Shibamoto Y, et al. Primary testicular non-Hodgkin’s lymphoma: a clinical study and review of the literature. Am J Clin Oncol. 1997;20:59–62.

    Article  PubMed  CAS  Google Scholar 

  11. Autorino R, Lamendola MG, De Sio M, Di Trolio RA, Ferraraccio F, Di Lorenzo G. A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report. Int J Immunopathol Pharmacol. 2007;20:401–3.

    PubMed  CAS  Google Scholar 

  12. Langar S, Sharma PK, Bhardwaj M, Kar HK. Cutaneous relapse of primary testicular non-Hodgkin lymphoma-the first sign of disease dissemination. Indian J Dermatol Venereol Leprol. 2010;76:576–8.

    Article  PubMed  Google Scholar 

  13. Avilés A, Neri N, Huerta-Guzmán J, Pérez F, Fernández R. Testicular lymphoma: organ-specific treatment did not improve outcome. Oncology. 2004;67:211–4.

    Article  PubMed  Google Scholar 

  14. Ornstein DL, Bifulco CB, Braddock DT, Howe JG. Histopathologic and molecular aspects of CD56 + natural killer/T-cell lymphoma of the testis. Int J Surg Pathol. 2008;16:291–300.

    Article  PubMed  CAS  Google Scholar 

  15. Kim YB, Chang SK, Yang WI, Hahn JS, Koom WS, Shim SJ, et al. Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol. 2003;109:95–100.

    Article  PubMed  Google Scholar 

  16. Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol. 1995;13:1361–7.

    PubMed  CAS  Google Scholar 

  17. Ostronoff M, Soussain C, Zambon E, Moran A, Droz JP, Bosq J, et al. Localized stage non-Hodgkin’s lymphoma of the testis: a retrospective study of 16 cases. Nouv Rev Fr Hematol. 1995;37:267–72.

    PubMed  CAS  Google Scholar 

  18. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–94.

    Article  Google Scholar 

  19. Vara Castrodeza A, Torres Nieto A, Mendo González M, Rodríguez Toves A, Peñarrubia Ponce MJ, de la Fuente Bobillo MA. Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging. Clin Transl Oncol. 2006;8:456–8.

  20. Li D, Xie P, Mi C. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype. Pathol Res Pract. 2010;206:611–5.

    Article  PubMed  CAS  Google Scholar 

  21. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.

    Article  PubMed  CAS  Google Scholar 

  22. Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases. Mod Pathol. 2006;19:1521–7.

    Article  PubMed  CAS  Google Scholar 

  23. Darby S, Hancock BW. Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol. 2005;26:1093–9.

    PubMed  Google Scholar 

  24. Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003;21:20–7.

    Article  PubMed  CAS  Google Scholar 

  25. Davis JW, Moriarty RP, Schlossberg SM, Schellhammer PF. Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor. Urology. 2001;57:555.

    Article  PubMed  CAS  Google Scholar 

  26. Zouhair A, Weber D, Belkacemi Y, Ketterer N, Dietrich PY, Villà S, et al. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2002;52:652–6.

    Article  PubMed  Google Scholar 

  27. Moller MB, d’Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer. 1994;30A:1760–4.

    Article  PubMed  CAS  Google Scholar 

  28. Singh LJ, Devi SB, Singh TA. Primary testicular lymphoma—a case report. J Indian Med Assoc. 2006;104:196–7.

    PubMed  Google Scholar 

  29. Aliferis K, Chan CC, Donati G, Baglivo E. Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years. Int Ophthalmol. 2008;28:439–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors were supported by a Grant (WC) from the National Natural Science Foundation of China (81000817).

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bingbing Shi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 74 kb)

About this article

Cite this article

Wang, C., Wang, H., Wang, Q. et al. Primary testicular lymphoma: experience with 13 cases and literature review. Int J Hematol 97, 240–245 (2013). https://doi.org/10.1007/s12185-013-1261-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-013-1261-8

Keywords

Navigation